Searched for
MURALI DIVI
Sell Divi's Laboratories, target price Rs 4,500: ICICI SecuritiesICICI Securities recommends a sell on Divi's Laboratories with a target price of Rs 4,500 despite recent quarterly growth. Management remai...- Daughter of Divi's founder shells out Rs 80 crore for two Hyderabad propertiesNilima Prasad Divi, daughter of Murali Divi, the founder of Divi's Laboratories, a prominent pharmaceutical company in India, has recently ...
- Buy Divi's Laboratories, target price Rs 3730: ICICI SecuritiesDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 94466.99 Crore) operating in Pharmace...
- Buy Divi's Laboratories, target price Rs 2912: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 76314.25 Crore) operating in Pharmace...
- Motilal Oswal Financial Services neutral on Divi's Laboratories, target price-Rs 2620Promoters held 51.94 per cent stake in the company as of 31-Dec-2022, while FIIs owned 15.15 per cent, DIIs 20.5 per cent.
- Buy Divi's Laboratories, target price Rs 3480: Reliance SecuritiesDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 90499.57 Crore) operating in Pharmace...
- At Rs 58.8 cr, Murali of Divi's Lab highest paid Indian pharma executiveThe percentage increase in the median remuneration for the staff of the firm for FY19 was 3.96 per cent.
- Buy Divi's Laboratories, target Rs 1,724: Kunal BothraBuy Divi's Laboratories Ltd. at a price target of Rs 1724.0 and a stoploss at Rs 1677 from entry point.
- Buy Divi's Laboratories, target Rs 1170: Manas JaiswalBuy Divi's Laboratories Ltd. at a price target of Rs 1170 and a stoploss at Rs 1095 from entry point.
- Buy Divi's Lab, target Rs 1220: Dr CK NarayanBuy Divi's Laboratories Ltd. at a price target of Rs 1220 and a stop loss at Rs 1185 from entry point.
- Buy Divi's Laboratories, target Rs 1,150: Kunal BothraBuy Divi's Laboratories Ltd. at a price target of Rs 1150.0 and a stop loss at Rs 1060 from entry point.
- Buy Divi's Laboratories, target Rs 1,100: Kunal BothraBuy Divi's Laboratories Ltd. at a price target of Rs 1100.0 and a stop loss at Rs 1040 from entry point.
- Buy Divi's Laboratories, target Rs 1,090: Shrikant ChouhanBuy Divi's Laboratories Ltd. at a price target of Rs 1090.0 and a stop loss at Rs 1030 from entry point.
- Sell Divi's Laboratories, target Rs 1,059.30: ICICI DirectSell Divi's Laboratories Ltd. at a price target of Rs 1059.3 and a stop loss at Rs 1090.2 from entry point.
- Buy Divi's Laboratories, target Rs 1,225: Nagaraj ShettiBuy Divi's Laboratories Ltd. at a price target of Rs 1225.0 and a stop loss at Rs 1015 from entry point.
- Buy Divi's Laboratories, target Rs 920: Chandan TapariaBuy Divi's Laboratories at a price target of Rs 920 and a stop loss at Rs 860 from entry point.
- Sell Divi's Laboratories, target Rs 900: Kunal BothraSell Divi's Laboratories Ltd. at a price target of Rs 900.0 and a stoploss at Rs 1044 from entry point.
- Sell Divi's Laboratories, target Rs 475.0 : Manas JaiswalSell Divi's Laboratories Ltd. at a price target of Rs 475.0 and a stop loss at Rs 606.0 from entry point
- Buy Divi's Laboratories, target Rs 678: Siddharth BhamreBuy Divi's Laboratories Ltd. at a price target of Rs 678.0 and a stop loss at Rs 609.0 from entry point
- Buy Divi's Laboratories Ltd. target Rs 660.0 : Sarvendra SrivastavaBuy Divi's Laboratories Ltd. at a price target of Rs 660.0 and a stoploss at Rs 618.4 from entry point
Load More
